EntryPoint Capital’s CME Group CME Stock Holding History

EntryPoint Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,051	Closed	-$554K	–	687
2025 Q3	$554K	Buy	2,051 +969	+90%	+$264K	0.21%	134
2025 Q2	$298K	Buy	+1,082	New	+$294K	0.15%	276
2024 Q4	–	Sell	-971	Closed	-$214K	–	759
2024 Q3	$214K	Buy	+971	New	+$201K	0.12%	430
2024 Q2	–	Sell	-71	Closed	-$15.3K	–	996
2024 Q1	$15.3K	Hold	71	–	–	0.01%	1153
2023 Q4	$15K	Buy	+71	New	+$15.1K	0.01%	1105

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EntryPoint Capital's CME Position: Q4 2025 in Review

EntryPoint Capital sold out of CME Group (CME) in Q4 2025, closing a stake of 2,051 shares — an estimated $554K sold.

EntryPoint Capital first reported a position in CME in Q4 2023 and held it in 5 quarters. The position peaked at $554K in Q3 2025. 1,731 funds tracked by Wall St. Rank hold CME as of Q4 2025.

EntryPoint Capital reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
EntryPoint Capital sold 2,051 CME Group shares in Q4 2025, an estimated $554K.
EntryPoint Capital first reported a position in CME Group in Q4 2023 and held it in 5 quarters.
EntryPoint Capital's CME Group position peaked at $554K in Q3 2025.
1,731 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.